Women's Health Ultrasound

Catch up on the top radiology content of the past week.

Catch up on the top AI-related news and research in radiology over the past month.

The artificial intelligence (AI)-powered applications reportedly allow clinicians to diagnose pulmonary edema and measure left ventricle ejection fraction within seconds.

One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.

Strain imaging analysis is one of the automated parameters included in the newly FDA-cleared Us2.v2 software for adjunctive review of echocardiographic images.

The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.

Catch up on the top radiology content of the past week.

A nomogram that combines contrast-enhanced lymphatic ultrasound and grayscale ultrasound findings had an 88 percent AUC for prediction of three or more metastatic axillary lymph nodes in women with early breast cancer.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

A multiparametric ultrasound model emphasizing attenuation coefficient assessment demonstrated a 77 percent AUC for detecting metabolic dysfunction-associated steatohepatitis (MASH), according to validation testing from a new multicenter study.

Catch up on the top radiology content of the past week.

In a comparison of image-to-text large language models (LLMs), ChatGPT 4.0 offered a 95 percent sensitivity rate and an 83 percent AUC that were comparable to that of two senior radiologists and one junior radiologist interacting with LLM to differentiate between malignant and benign thyroid nodules on ultrasound.

While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.

Designed for full-body imaging, the new modality reportedly offers a lightweight portable design, AI-powered tools and enhanced high-resolution images.

Catch up on the most-well viewed radiology content in February 2024.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

What does the current evidence reveal for four FDA-cleared AI software modalities for breast ultrasound? Leading researchers review the study findings in a recently published literature review.

Recently cleared by the FDA, the iQ3 point-of-care ultrasound system reportedly offers new advances in 3D imaging capabilities.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in January 2024.

Reportedly providing enhanced imaging of structural heart disease, the minimally invasive X11 4t Mini 3D TEE ultrasound transducer facilitates use of the technology in smaller pediatric patients as well as high-risk ICU patients.

Catch up on the top radiology content of the past week.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

Noting the challenges with angiography in the imaging of lower extremity revascularization, a panel of interventional radiologists, interventional cardiologists and vascular surgeons discussed emerging evidence that supports the use of intravascular ultrasound in facilitating improved outcomes in this high-risk patient population.

The BioTraceIO software reportedly facilitates visualization of liver tumor ablation procedures based on real-time ultrasound imaging and provides superior post-op estimates of ablation zone volume in comparison to computed tomography.

Catch up on the top radiology content of the past week.

In a recent proof-of-concept trial assessing the combination of aducanumab infusion with MRI-guided focused ultrasound to open the blood-brain barrier, researchers found significant reductions in amyloid-beta load at 26 weeks in patients with Alzheimer’s disease.